Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaon Joy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|February 28, 2022
Small molecule peptidomimetic trypsin inhibitors: validation of an EKO binding mode, but with a twistRui-Liang Lyu, Shaon Joy, Charles Packianathan, et al.
Frontiers in Medicine|September 12, 2022
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye diseaseZhiyuan Yu, Shaon Joy, Tianxiong Mi, et al.
Biomaterials|July 4, 2012
Prion inhibition with multivalent PrPSc binding compoundsCharles E Mays, Shaon Joy, Lei Li, et al.
ACS Chemical Neuroscience|July 9, 2025
Selective Modulation of Trk Receptors by <i>Cyclo</i>-OrganopeptidesShaon Joy, Tianxiong Mi, Rui-Liang Lyu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|February 28, 2022
Small molecule peptidomimetic trypsin inhibitors: validation of an EKO binding mode, but with a twistRui-Liang Lyu, Shaon Joy, Charles Packianathan, et al.
Frontiers in Medicine|September 12, 2022
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye diseaseZhiyuan Yu, Shaon Joy, Tianxiong Mi, et al.
Biomaterials|July 4, 2012
Prion inhibition with multivalent PrPSc binding compoundsCharles E Mays, Shaon Joy, Lei Li, et al.
ACS Chemical Neuroscience|July 9, 2025
Selective Modulation of Trk Receptors by <i>Cyclo</i>-OrganopeptidesShaon Joy, Tianxiong Mi, Rui-Liang Lyu, et al.
Pageof 1